PIRS NASDAQ
Pieris Pharmaceuticals, Inc.
1W: -16.7%
1M: -15.5%
3M: -18.1%
1Y: +21.4%
3Y: -94.6%
5Y: -95.2%
$13.60
Last traded 2024-12-13 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+100.0% YoY
$-62M
Net Income
-131.9% YoY
$-31M
Free Cash Flow
-52.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-46.6%
ROA-37.7%
ROIC51.0%
Valuation
P/E-2.8
P/B0.9
EV/EBITDA2.8
Leverage
Debt/Equity0.00
Current Ratio21.18
Interest Cov.-286.1x
Quality Scores
Piotroski F3/9
Altman Z3.23
Beneish M0.00